AlanC
I know you are a student of shorts sales and even
AlanC
I know you are a student of shorts sales and even naked short sales. What does all of this daily FINRA short sale evidence tell you.
If we assume that every day in the last 2 weeks there have been 12,000,000 sales, and further assume that shorts are 25% of every days transactions; that is 3,000,000 short sales per day.
Are the shorts successfully closing each of these transactions within 3 trading days, and still find it possible to control the stock price as they have?
Is it still possible to retain a naked position? Are Market Makers still loaning out their ability to create naked positions to their customers?
On the other side of the coin, if the short positions have not been closed at all, and all shorts are supported by a borrow: then there are now 30,000,000 new short positions added to the enormous short position created just to take the stock down to .007 from .023 where I originally started to buy. That selling activity was aided only by the fact that NTEK was selling new shares into the market without good news.
And then we have to talk about the borrowing cost to maintain such a staggering short position.....
And then we have to talk about the Risk of Loss vs their potential gain of forcing NTEK stock value to go to 0. The most they could gain would be some percentage of our 5,800,000 equity. Even if we assumed that shorts were 50% of NTEK the most they gain from this point is 2,900,000. Granted, the shorts that started at .05 have more to gain and they are still easily profitable; but I would bet that most of those positions have been closed on the way down to .007.
A short closing out a profitable position today that had even a bit of common sense and is obviously a risk taker/evaluator should be a natural long preparing for the trip back up.
So why continue to short today? Who are these guys?
Paul
Nanotech Entertainment Inc. (NTEK) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...
Continue Reading
Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...
Continue Reading
Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...
Continue Reading
Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...
Continue Reading
Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...
Continue Reading
Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...
Continue Reading
Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...
Continue Reading
Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...
Continue Reading
Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...
Continue Reading
Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of Aalberts' Share Buyback Program Aalberts has recently announced the progress of its ongoing share buyback program, giving investors and shareholders a detailed look into its current operations. This program is part of a strategic initiative to enhance shareholder value and demonstrate confidence in the company's long-term prospects. Recent Share Repurchase...
Continue Reading
American Water's Recognition on Newsweek’s List American Water (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., is proud to announce its inclusion in Newsweek’s list of America’s Most Responsible Companies for 2025. This honor reflects American Water's unwavering commitment to environmental, social, and governance (ESG)...
Continue Reading
Pendulum Ink Innovates Online Hip-Hop Education Pendulum Ink, recognized as the world's first online hip-hop academy, has made headlines with its recent relaunch featuring a subscription-based model. This new structure is designed to provide flexible engagement tiers, making hip-hop education accessible to learners around the globe. The relaunch not only aims to educate...
Continue Reading
Mach7 Technologies Introduces UnityVue for Radiology Mach7 Technologies is thrilled to announce the release of UnityVue, an advanced, AI-driven workflow orchestration solution designed to enhance patient care, alleviate radiologist burnout, and optimize diagnostic workflows. This innovative platform aims to create a more efficient radiology environment, making it a...
Continue Reading
Purina Teams Up with UC Davis School of Veterinary Medicine Nestlé Purina PetCare is thrilled to share a groundbreaking partnership with the University of California, Davis. This collaboration is focused on improving our understanding of urinary health in pets. With the support of a generous grant, this initiative represents a major step forward in scientific research...
Continue Reading